アッヴィ株式会社
MX ˙ BMV ˙ US00287Y1091
SecurityMX:ABBV / AbbVie Inc.
InstitutionSevenBridge Financial Group, LLC
Latest Disclosed Ownership15,172 shares
Latest Disclosed Value $ 3,041,917
SevenBridge Financial Group, LLC reports 1.56% decrease in ownership of ABBV / AbbVie Inc.

On April 23, 2026 - SevenBridge Financial Group, LLC filed a 13F-HR form disclosing ownership of 15,172 shares of AbbVie Inc. (MX:ABBV) valued at $3,041,917 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 2, 2026 disclosing 15,412 shares of AbbVie Inc.. This represents a change in shares of -1.56% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-04-23 2026-03-31 13F ABBVIE COM 00287Y109 15,172 -240 -1.56 3,042 -10.61 0.4755
2026-02-02 2025-12-31 13F ABBVIE COM 00287Y109 15,412 -75 -0.48 3,402 -5.79 0.5471
2025-11-13 2025-09-30 13F ABBVIE COM 00287Y109 15,487 -2,204 -12.46 3,612 2.76 0.5954
2025-09-04 2025-06-30 13F ABBVIE COM 00287Y109 17,691 -1,192 -6.31 3,514 -2.09 0.6195
2025-05-13 2025-03-31 13F ABBVIE COM 00287Y109 18,883 -1,591 -7.77 3,589 -8.61 0.7062
2025-02-12 2024-12-31 13F ABBVIE COM 00287Y109 20,474 -418 -2.00 3,927 7.77 0.7429
2024-11-12 2024-09-30 13F ABBVIE COM 00287Y109 20,892 363 1.77 3,644 -4.41 0.7020
2024-08-09 2024-06-30 13F ABBVIE COM 00287Y109 20,529 268 1.32 3,812 14.89 0.8432
2024-05-10 2024-03-31 13F ABBVIE COM 00287Y109 20,261 -160 -0.78 3,318 4.87 0.7518
2024-01-22 2023-12-31 13F ABBVIE COM 00287Y109 20,421 -88 -0.43 3,165 3.50 0.7476
2023-10-25 2023-09-30 13F ABBVIE COM 00287Y109 20,509 415 2.07 3,057 12.93 0.7900
2023-07-26 2023-06-30 13F ABBVIE COM 00287Y109 20,094 126 0.63 2,707 -14.93 0.6990
2023-04-20 2023-03-31 13F ABBVIE COM 00287Y109 19,968 390 1.99 3,182 0.60 0.8771
2023-01-26 2022-12-31 13F AbbVie COM 00287Y109 19,578 155 0.80 3,164 21.33 0.9252
2022-10-17 2022-09-30 13F ABBVIE COM 00287Y109 19,423 7,915 68.78 2,607 47.87 0.8833
2022-07-12 2022-06-30 13F AbbVie Equities 00287Y109 11,508 -13 -0.11 1,763 -5.62 0.7128
2022-04-15 2022-03-31 13F AbbVie COM 00287Y109 11,521 -1,645 -12.49 1,868 4.77 0.6558
2022-01-20 2021-12-31 13F/A-1 AbbVie COM 00287Y109 13,166 1,868 16.53 1,783 46.27 0.5391
2021-10-14 2021-09-30 13F AbbVie Equities 00287Y109 11,298 -303 -2.61 1,219 -6.73 0.4063
2021-07-26 2021-06-30 13F AbbVie Equities 00287Y109 11,601 732 6.73 1,307 11.14 0.4261
2021-04-20 2021-03-31 13F AbbVie Equities 00287Y109 10,869 484 4.66 1,176 5.66 0.4279
2021-01-19 2020-12-31 13F AbbVie Equities 00287Y109 10,385 1,835 21.46 1,113 48.60 0.4351
2020-10-22 2020-09-30 13F AbbVie Equities 00287Y109 8,550 142 1.69 749 -9.21 0.3409
2020-07-24 2020-06-30 13F AbbVie Equities 00287Y109 8,408 -280 -3.22 825 24.62 0.4097
2020-04-16 2020-03-31 13F AbbVie Equities 00287Y109 8,688 891 11.43 662 -4.06 0.3832
2020-01-17 2019-12-31 13F AbbVie Equities 00287Y109 7,797 617 8.59 690 26.84 0.1803
2019-10-09 2019-09-30 13F AbbVie Equities 00287Y109 7,180 -517 -6.72 544 -2.86 0.2861
2019-07-15 2019-06-30 13F AbbVie Equities 00287Y109 7,697 460 6.36 560 -3.95 0.2006
2019-05-14 2019-03-31 13F AbbVie Equities 00287Y109 7,237 -131 -1.78 583 -14.14 0.2188
2019-02-14 2018-12-31 13F AbbVie Equities 00287Y109 7,368 -16,706 -69.39 679 -70.18 0.4155
2018-11-14 2018-09-30 13F AbbVie Equities 00287Y109 24,074 -189 -0.78 2,277 1.29 1.2102
2018-08-14 2018-06-30 13F AbbVie Equities 00287Y109 24,263 496 2.09 2,248 -0.09 1.2522
2018-05-11 2018-03-31 13F AbbVie Equities 00287Y109 23,767 60 0.25 2,250 -1.88 1.2910
2018-02-16 2017-12-31 13F AbbVie Equities 00287Y109 23,707 -501 -2.07 2,293 6.60 1.2682
2017-11-13 2017-09-30 13F AbbVie Equities 00287Y109 24,208 819 3.50 2,151 26.83 1.2325
2017-08-14 2017-06-30 13F AbbVie Common Stock 00287Y109 23,389 9,798 72.09 1,696 90.35 1.0354
2017-05-15 2017-03-31 13F AbbVie CS 00287Y109 13,591 -3,301 -19.54 891 -13.75 0.5853
2017-02-03 2016-12-31 13F AbbVie CS 00287Y109 16,892 0 0.00 1,033 0.00 0.7502
2016-12-20 2016-09-30 13F/A-1 AbbVie CS 00287Y109 16,892 970 6.09 1,033 4.77 0.7525
2016-11-28 2016-09-30 13F AbbVie CS 00287Y109 16,892 1,033
2016-08-15 2016-06-30 13F AbbVie CS 00287Y109 15,922 15,922 986 0.6909
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.